Molecular basis of human CD22 function and therapeutic targeting

CD22 maintains a baseline level of B-cell inhibition to keep humoral immunity in check. As a B-cell-restricted antigen, CD22 is targeted in therapies against dysregulated B cells that cause autoimmune diseases and blood cancers. Here we report the crystal structure of human CD22 at 2.1 Å resolution,...

Descripción completa

Detalles Bibliográficos
Autores principales: Ereño-Orbea, June, Sicard, Taylor, Cui, Hong, Mazhab-Jafari, Mohammad T., Benlekbir, Samir, Guarné, Alba, Rubinstein, John L., Julien, Jean-Philippe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5624926/
https://www.ncbi.nlm.nih.gov/pubmed/28970495
http://dx.doi.org/10.1038/s41467-017-00836-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5624926/
https://www.ncbi.nlm.nih.gov/pubmed/28970495
http://dx.doi.org/10.1038/s41467-017-00836-6

Ejemplares similares